Friday, March 14, 2025
spot_img

Pyxis Tankers Announces Date for the Release of the Fourth Quarter & Year Ended 2024 Results

Maroussi, Greece, March 11, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international shipping company with a focus on the seaborne transportation of refined petroleum products and dry bulk commodities, today announced the following:

We will issue our unaudited results for the fourth quarter and year ended December 31, 2024, after the market closes in New York on Thursday, March 13.

A presentation of the fourth quarter and year-end 2024 financial results will be available on the Pyxis Tanker’s website, under the  Presentations section of its Investor Relations page.

About Pyxis Tankers Inc.

The Company currently owns a modern fleet of six mid-sized eco-vessels, which are engaged in the seaborne transportation of a broad range of refined petroleum products and dry bulk commodities and consists of three MR product tankers, one Kamsarmax bulk carrier and controlling interests in two dry bulk joint ventures of a sister-ship Kamsarmax and an Ultramax. The Company is positioned to opportunistically expand and maximize its fleet of eco-efficient vessels due to significant capital resources, competitive cost structure, strong customer relationships and an experienced management team whose interests are aligned with those of its shareholders.


Company
Pyxis Tankers Inc.
59 K. Karamanli Street
Maroussi, 15125 Greece
[email protected]

Visit our website at www.pyxistankers.com


Company Contact
Henry Williams
Chief Financial Officer
Tel: +30 (210) 638 0200 / +1 (516) 455-0106
Email: [email protected]

Source: Pyxis Tankers Inc.

Powered by SlickText.com

Hot this week

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Topics

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Parsons to Present at the Bank of America Global Industrials Conference

CHANTILLY, Va., March 13, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img